港股公告掘金 | 宁德时代今日起招股发售价将不高于263港元

智通财经2025-05-12

【重大事项】宁德时代(03750)拟全球发售1.18亿股H股引入中石化(香港)作为基石投资者石药集团(01093)：富马酸伏诺拉生片获药品注册批件远大医药(00512)创新放射性核素偶联药物 TLX591-CDx 中国 III 期临床研究完成全部患者入组给药并计划今年内递交上市申请荣昌生物(09995)：维迪西妥单抗一线治疗HER2表达的尿路上皮癌Ⅲ期临床研究达到主要研究终点复星医药(02196...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2534208735?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-12 23:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2534208735","market":"hk","top_or_hot":-1,"title":"港股公告掘金 | 宁德时代今日起招股 发售价将不高于263港元","media":"智通财经","content":"<div>\n<p>【重大事项】宁德时代(03750)拟全球发售1.18亿股H股 引入中石化(香港)作为基石投资者石药集团(01093)：富马酸伏诺拉生片获药品注册批件远大医药(00512)创新放射性核素偶联药物 TLX591-CDx 中国 III 期临床研究完成全部患者入组给药并计划今年内递交上市申请荣昌生物(09995)：维迪西妥单抗一线治疗HER2表达的尿路上皮癌Ⅲ期临床研究达到主要研究终点复星医药(02196...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1292255.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股公告掘金 | 宁德时代今日起招股 发售价将不高于263港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股公告掘金 | 宁德时代今日起招股 发售价将不高于263港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-12 23:02 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1292255.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【重大事项】宁德时代(03750)拟全球发售1.18亿股H股 引入中石化(香港)作为基石投资者石药集团(01093)：富马酸伏诺拉生片获药品注册批件远大医药(00512)创新放射性核素偶联药物 TLX591-CDx 中国 III 期临床研究完成全部患者入组给药并计划今年内递交上市申请荣昌生物(09995)：维迪西妥单抗一线治疗HER2表达的尿路上皮癌Ⅲ期临床研究达到主要研究终点复星医药(02196...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1292255.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0823414478.USD","symbol_name":"法巴经典能源转换基金","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1292255.html","article_id":"2534208735","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2534208735","pubTimestamp":1747062136,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"【重大事项】宁德时代(03750)拟全球发售1.18亿股H股 引入中石化(香港)作为基石投资者石药集团(01093)：富马酸伏诺拉生片获药品注册批件远大医药(00512)创新放射性核素偶联药物 TLX591-CDx 中国 III 期临床研究完成全部患者入组给药并计划今年内递交上市申请荣昌生物(09995)：维迪西妥单抗一线治疗HER2表达的尿路上皮癌Ⅲ期临床研究达到主要研究终点复星医药(02196","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0823414478.USD":"法巴经典能源转换基金","01875":"东曜药业-B","LU0823414551.USD":"BNP PARIBAS ENERGY TRANSITION \"C\" (USD) INC","LU0132412106.USD":"abrdn SICAV I - EMERGING MARKETS EQUITY \"A\" (USD) ACC","LU2476274720.SGD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"AT\" (SGDHDG) ACC","LU1934453819.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"A\" (USD) ACC","LU0516422440.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","LU2097828805.USD":"AZ EQUITY CHINA \"A-AZ\" (USD) ACC","LU0359201885.HKD":"BGF CHINA \"A2\" (HKD) ACC","LU0651947912.USD":"BGF EMERGING MARKETS EQUITY INCOME \"A5G\" (USD) INC","LU1152091168.USD":"UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) \"PM\" INC","LU1997244956.HKD":"ALLIANZ CHINA A-SHARES \"AT\" (HKD) ACC A","SGXZ81163826.USD":"UNITED CHINA A-SHARES INNOVATION \"A\" (USD) ACC","IE0003851619.USD":"BNY MELLON ASIAN EQUITY \"B\" (USD) ACC","HSTECH":"恒生科技指数","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","SGXZ49509284.SGD":"United China A Shares Innovation A Acc SGD","LU0029875118.USD":"TEMPLETON ASIAN GROWTH \"A\" INC","LU2348773727.SGD":"Aberdeen Standard SICAV I - Asian Sustainable Development Equity A Acc SGD-H","03750":"宁德时代","LU2424517915.HKD":"abrdn SICAV I -  ASIAN SDG EQUITY \"A\" (HKD) ACC","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","LU0269904917.USD":"SCHRODER ISF GLOBAL EMERGING MARKET OPPORTUNITIES \"A\" (USD) ACC","BK1589":"北水核心资产","LU0302445910.USD":"SCHRODER ISF GLOBAL CLIMATE CHANGE EQUITY \"A\" ACC","IE00BZ08YT58.USD":"GUINNESS BEST OF CHINA \"C\" (USD) ACC","LU0228659784.USD":"施罗德金砖四国基金","LU1861214812.USD":"Blackrock Future of Transport A2 USD","IE0003795394.USD":"BNY MELLON ASIAN EQUITY \"A\" (USD) ACC","SG9999002828.SGD":"Eastspring Investments Unit Trusts - Dragon Peacock A SGD","BK4519":"光伏太阳能","EVS.SI":"MSCI China Electric Vehicles and Future Mobility ETF-NikkoAM","01093":"石药集团","LU1720050803.USD":"安联全方位中国股票基金","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","BK1608":"元宇宙概念","LU1515016050.SGD":"Blackrock Emerging Markets Equity Income A6 SGD-H","02382":"舜宇光学科技","LU1226287875.USD":"UBS (LUX) KEY SEL S-CHINA ALLOCATION OPP \"PM\" (USD) INC","LU2275660780.HKD":"SCHRODER ISF GLOBAL CLIMATE CHANGE EQUITY \"A\" (HKD) ACC","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC","00512":"远大医药","LU1719994722.HKD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (HKD) ACC","YANG":"三倍做空富时中国ETF-Direxion","LU0871576103.HKD":"HSBC GIF CHINESE EQUITY \"AC\" (HKD) ACC","JKS":"晶科能源"},"translate_title":"Hong Kong stock announcement Nuggets Contemporary Amperex Technology Co., Limited will start IPO today and the offering price will not be higher than HK $263","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"90132":0.6,"JKS":1,"01093":0.9,"00512":0.9,"02382":0.9,"HSTECH":1,"YANG":1,"EVS.SI":0.6,"03750":1,"01875":0.9},"content_text":"【重大事项】宁德时代(03750)拟全球发售1.18亿股H股 引入中石化(香港)作为基石投资者石药集团(01093)：富马酸伏诺拉生片获药品注册批件远大医药(00512)创新放射性核素偶联药物 TLX591-CDx 中国 III 期临床研究完成全部患者入组给药并计划今年内递交上市申请荣昌生物(09995)：维迪西妥单抗一线治疗HER2表达的尿路上皮癌Ⅲ期临床研究达到主要研究终点复星医药(02196)：FCN-159 片用于治疗儿童朗格汉斯组织细胞增生症已被纳入突破性治疗药物程序中国中车(01766)及下属企业近期签订若干项重大合同 涉资约547.4亿元知行科技(01274)将收购小工匠机器人大部分股份【财报数据】舜宇光学科技(02382)4月手机镜头出货量1.03亿件，同比增长1.3%裕元集团(00551)4月综合经营收益净额6.58亿美元，同比增加1.2%宝胜国际(03813)前4个月综合累计经营收益净额约64.81亿元，同比下跌7.7%东曜药业-B(01875)第一季度营业收入同比增长13%至2.52亿元裕元集团(00551)公布第一季度业绩 公司拥有人应占溢利7575.8万美元 同比减少24.2%宝胜国际(03813)公布第一季度业绩 公司拥有人应占溢利约1.38亿元 同比减少20.65%","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2534208735","isCrawlerRequest":true}

港股公告掘金 | 宁德时代今日起招股 发售价将不高于263港元

精彩评论

港股公告掘金 | 宁德时代今日起招股发售价将不高于263港元